Barbara Hunt

4.1k citations

68 papers · 3.0k indexed · 3 hit papers · h-index 27

Impact in

Nephrology top 0.2%
- Gout, Hyperuricemia, Uric Acid
Gastroenterology top 1%
- Gastroesophageal reflux and treatments

Papers in

Gastroenterology 24
- Gastroesophageal reflux and treatments 24
Nephrology 21
- Gout, Hyperuricemia, Uric Acid 19

Co-authors: Michael A. Becker Patricia MacDonald Lhanoo Gunawardhana Andrew Whelton Kenneth G. Saag Nancy Joseph‐Ridge Robert L. Wortmann William B. White
Journals: Alimentary Pharmacology & Therapeutics (8 papers)Gastroenterology (6 papers)The American Journal of Gastroenterology (6 papers)Digestive Diseases and Sciences (5 papers)Arthritis & Rheumatology (4 papers)
Partner nations: United States Canada France

In The Last Decade

Barbara Hunt

64 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial 2022 · 177 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Gastroenterology
2018 New England Journal of Medicine
2008 Arthritis Care & Research

Peers

Countries citing papers authored by Barbara Hunt

Since Specialization

Citations

This map shows the geographic impact of Barbara Hunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Hunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Hunt more than expected).

Fields of papers citing papers by Barbara Hunt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Hunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Hunt. The network helps show where Barbara Hunt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barbara Hunt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Hunt Line = papers co-authored together Barbara Hunt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon‐HP trial JGH Open ·William D. Chey, Françis Mégraud, Loren Laine, Neila Smith, Eckhard Leifke, Barbara Hunt, Colin W. Howden	2024	1
2	Sa1373 HELICOBACTER PYLORI ERADICATION RATES WITH VONOPRAZAN: SUBGROUP ANALYSIS FROM THE PHASE 3 PHALCON HP TRIAL Gastroenterology ·William D. Chey, Françis Mégraud, Loren Laine, Neila Smith, Eckhard Leifke, Barbara Hunt, Colin W. Howden	2023	0
3	Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial Arthritis Research & Therapy ·(unknown), Peter C. Taylor, Ana Blanco Guada, Jiří Vencovský, Tsutomu Takeuchi, Tadashi Nakamura, 조태준, Barbara Hunt, Thomas E. Wagner, Bernard Souberbielle	2019	69
4	Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout New England Journal of Medicine ·William B. White, Kenneth G. Saag, Michael A. Becker, Jeffrey Borer, Philip B. Gorelick, Andrew Whelton, Barbara Hunt, D J Mayers, Lhanoo Gunawardhana Hit paper breakdown →	2018	578
5	Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease Digestive Diseases and Sciences ·Benjamin D. Gold, Betsy Pilmer, Jarosław Kierkuś, Barbara Hunt, María Claudia Pérez, David A. Gremse	2017	6
6	The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole Alimentary Pharmacology & Therapeutics ·David A. Peura, Betsy Pilmer, Barbara Hunt, Reema Mody, María Claudia Pérez	2013	17
7	CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES American Heart Journal ·William B. White, Saima Chohan, Hans-Georg Werner, Barbara Hunt, Robert L. Jackson	2012	48
8	The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age BMC Geriatrics ·Robert L. Jackson, Barbara Hunt, Patricia MacDonald	2012	37
9	Treating Hyperuricemia of Gout: Safety and Efficacy of Febuxostat and Allopurinol in Older Versus Younger Subjects Nucleosides Nucleotides & Nucleic Acids ·Michael A. Becker, Patricia MacDonald, Barbara Hunt, Lhanoo Gunawardhana	2011	10
10	Long-Term Quality of Life Improvement in Subjects with Healed Erosive Esophagitis: Treatment with Lansoprazole Digestive Diseases and Sciences ·Thomas O. Kovacs, James W. Freston, Marian M. Haber, Stuart Atkinson, Barbara Hunt, David A. Peura	2009	6
11	The clinical safety of long‐term lansoprazole for the maintenance of healed erosive oesophagitis Alimentary Pharmacology & Therapeutics ·James W. Freston, Michie Hisada, David A. Peura, Marian M. Haber, T. O. G. Kovacs, Stuart Atkinson, Barbara Hunt	2009	14
12	Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy Nucleosides Nucleotides & Nucleic Acids ·Michael A. Becker, Patricia MacDonald, Barbara Hunt, Christopher Lademacher, Nancy Joseph‐Ridge	2008	73
13	Lansoprazole for Long-Term Maintenance Therapy of Erosive Esophagitis: Double-Blind Comparison with Ranitidine Digestive Diseases and Sciences ·David A. Peura, James W. Freston, Marian M. Haber, Thomas O. Kovacs, Barbara Hunt, Stuart Atkinson	2008	5
14	Celecoxib Plus Aspirin Versus Naproxen and Lansoprazole Plus Aspirin: A Randomized, Double-Blind, Endoscopic Trial Clinical Gastroenterology and Hepatology ·Jay L. Goldstein, Byron Cryer, Bruce M. Gatenby, Barbara Hunt	2007	29
15	Lansoprazole regimens that sustain intragastric pH >6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages Alimentary Pharmacology & Therapeutics ·David C. Metz, Bruce M. Gatenby, Barbara Hunt, Majid Vakily, Michael Kukulka, Christian Berndt	2006	27
16	Dose–response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h Alimentary Pharmacology & Therapeutics ·Colin W. Howden, David C. Metz, Barbara Hunt, Majid Vakily, Michael Kukulka, Bruce M. Gatenby, Christian Berndt	2006	13
17	Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections Clinical Therapeutics ·A Bucko, Barbara Hunt, 杨晖, Niklas Ortelbach	2002	31
18	Causes of death and risk factors in young and old diabetic patients referred to a retinopathy clinic Journal of Diabetes and its Complications ·Christopher J. Bulpitt, Marcus A. Sleightholm, Barbara Hunt, Astrid Fletcher, A. W. Palmer, Eva M. Kohner	1996	2
19	Direct correlation between MUC18 expression and metastatic potential of human melanoma cells Melanoma Research ·Mario Luca, Barbara Hunt, C D Bucana, Jennifer Johnson, Isaiah J. Fidler, E. N. Matveishin	1993	103
20	Retention of immunogenicity after X-irradiation of mouse colon tumor cells expressing the transfected influenza virus hemagglutinin gene Cancer Immunology Immunotherapy ·Toshiyuki Itaya, Barbara Hunt, Adhika Pramita Widyassari	1989	3

About Barbara Hunt

Barbara Hunt is a scholar working on Gastroenterology, Nephrology, Hepatology, Surgery and Rheumatology, having authored 68 papers that have together received 3.0k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (25 papers), Gastroesophageal reflux and treatments (24 papers), Gout, Hyperuricemia, Uric Acid (19 papers), Eosinophilic Esophagitis (18 papers), Case Reports on Hematomas (15 papers), Urticaria and Related Conditions (5 papers), Liver Disease and Transplantation (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Nephrology (1.7k citations), Gastroenterology (426 citations), Rheumatology (743 citations), Surgery (1.6k citations) and Hepatology (273 citations). Barbara Hunt has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Michael A. Becker, Patricia MacDonald, Lhanoo Gunawardhana, Andrew Whelton, Kenneth G. Saag, Nancy Joseph‐Ridge, Robert L. Wortmann, William B. White, Christopher Lademacher and Philip B. Gorelick. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Gastroenterology, The American Journal of Gastroenterology, Digestive Diseases and Sciences and Arthritis & Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact